Key Takeaways Bio-Techne unveiled RNAscope and COMET advances in spatial biology for clinical utility workflows.TECH shares climbed 2.7% to $51.85 after the Sept. 26 announcement of these innovations. TECH's presentations at the NSH Convention will highlight RNAscope and COMET's diagnostic potential.Bio-Techne Corporation (TECH) recently announced new advancements in its spatial biology portfolio for the RNAscope ISH technology and the Lunaphore COMET. Research highlights the potential role of these solutio ...